⌘K

Login Start Free

Home/Filings/4/0001209191-15-078145

4//SEC Filing

MERRIMACK PHARMACEUTICALS INC 4

Accession 0001209191-15-078145

CIK 0001274792operating

View on SEC.gov Company Profile

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 5:30 PM ET

Size

13.8 KB

Accession

0001209191-15-078145

Insider Transaction Report

Form 4

Period: 2015-11-02

MERRIMACK PHARMACEUTICALS INCMACK

Stewart Edward J.

SVP & Pres, Healthcare Sol

Transactions

Sale
Common Stock
2015-11-02$9.30/sh−5,000$46,500→ 21,385 total
Exercise/Conversion
Common Stock
2015-11-02$1.81/sh+5,000$9,050→ 26,385 total
Exercise/Conversion
Common Stock
2015-11-02$1.81/sh+1,000$1,810→ 22,385 total
Exercise/Conversion
Stock Option (right to buy)
2015-11-02−5,000→ 18,000 total
Exercise: $1.81Exp: 2018-09-22→ Common Stock (5,000 underlying)
Sale
Common Stock
2015-11-02$10.00/sh−1,000$10,000→ 21,385 total
Exercise/Conversion
Stock Option (right to buy)
2015-11-02−1,000→ 17,000 total
Exercise: $1.81Exp: 2018-09-22→ Common Stock (1,000 underlying)

Footnotes (2)

[F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
[F2]This option is fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

MERRIMACK PHARMACEUTICALS INC

CIK 0001274792

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001274792

Filing Metadata

Form type: 4
Filed: Nov 2, 7:00 PM ET
Accepted: Nov 3, 5:30 PM ET
Size: 13.8 KB

View on SEC.gov